A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness
- 8 January 2011
- Vol. 29 (10) , 1921-1928
- https://doi.org/10.1016/j.vaccine.2010.12.100
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Use of a Mandatory Declination Form in a Program for Influenza Vaccination of Healthcare WorkersInfection Control & Hospital Epidemiology, 2008
- A dose–response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adultsVaccine, 2007
- Vaccines for preventing influenza in healthy adultsPublished by Wiley ,2007
- Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adultsVaccine, 2006
- Fear of needles and vasovagal reactions among phlebotomy patientsPublished by Elsevier ,2006
- Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjectsVaccine, 2006
- Multiplex Real-Time PCR Assay for Detection of Influenza and Human Respiratory Syncytial VirusesJournal of Clinical Microbiology, 2004